The Pennant Group Corp (PNTG): Broker Consensus Forecast

Brandmark of Pennant Group Inc (PNTG)

The Pennant Group, Inc. (PNTG) generates revenue by supporting elderly Americans, receiving payments from insurance companies and government programs for rehabilitation and hospice care. The operating model relies on external IT contractors for billing and supply chain management, while medical staff remain in-house. The current figure is 48.19. The current price action below demonstrates the company's asset value amid maximum capacity utilization of its modernized centers.

PNTG - The Pennant Group, Inc. Analyst Consensus Forecast over the range 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for Pennant Group Inc (PNTG)

- share price and expert price forecast:
General company analysis:PNTG - pennantgroup.com
Brand item of The Pennant Group Corp

The Pennant Group, Inc. (PNTG) is protected by high barriers to entry due to strict Medicare licensing and labor shortages. By analyzing the consensus benchmark of market experts, an investor assesses the average analyst expectation for the asset's value. Rising price targets often mask a fundamental slowdown in revenue, justifying inflated multiples. This indicator measures the degree of market optimism regarding the future price. A stable trend confirms Wall Street's long-term confidence in the business's resilience.

Competing companies

HCA: Forecast Levels Chart|Price Target Chart Tenet Healthcare Corporation THC|FMS: Broker Consensus Forecast|SOLV: Consensus Target|Encompass - Analyst Forecast Prices|UHS: Analyst Consensus Forecast|Analyst Target Range davita.com DVA|Consensus Target RDNT|OPCH (Option Care) - Analyst Forecast Prices|Price Target Chart Surgery Partners Corp (SGRY)|PINC (Premier Health) - Fair Value Consensus|Analyst Consensus Forecast EYE (National Vision Holdings)|progyny.com (PGNY) - Average Forecast Price|Ardent Health Partners - Analyst Consensus Forecast|SEM - Analyst Consensus Forecast|ASTH (Apollo Medical Holdings) - Consensus Target|MD: Analyst Forecast Prices|Price Target Chart US Physical Therapy|Consensus Target organogenesis.com (ORGO)|Analyst Consensus Forecast NUTX|AUNA - Average Forecast Price|Price Target Chart sbc-holdings.com SBC|EOLS: Broker Consensus Forecast|CYH: Consensus Target|The Beauty Health - Analyst Forecast Prices|MDWD (mediwound.com) - Consensus Target|BTMD: Analyst Forecast Prices|JYNT (The Joint Corporation) - Analyst Consensus Forecast|DCGO: Fair Value Consensus|Analyst Consensus Forecast PIII|GANX - Average Forecast Price|EUDA Health - Consensus Target|Fair Value Consensus BMGL|CLGN - Price Target Chart|Forecast Levels Chart CUPR|CCM: Analyst Consensus Forecast|Average Forecast Price ashs.com (AMS)|Price Target Chart MEDIROM Healthcare Group|Broker Consensus Forecast ALBT (Avalon GloboCare Corporation)|Price Target Chart DIH Holding US Inc. (DHAI)|Carmell Corp - Broker Consensus Forecast|Analyst Consensus Forecast NIVF (NewGenIvf Group Limited)|Analyst Consensus Forecast ATI Physical Therapy Inc. ATIP|CMAX - Price Target Chart|KDLY (Kindly MD Inc) - Broker Consensus Forecast|MODV (LogistiCare) - Consensus Target|NVOS: Analyst Forecast Prices|Consensus Target SSY|BACK: Fair Value Consensus